newcleo (or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced a significant regulatory milestone for its planned mixed-oxide ("MOX") fuel facility in France. The company is also entering a new phase of collaboration with French authorities following the evaluation of newcleo's application for Phase 2 of the France 2030 innovative nuclear reactor program.

The French Nuclear Safety and Radiation Protection Authority (Autorité de sûreté nucléaire et de radioprotection) ("ASNR") has published on 13 July 2026 its opinion on all the safety features proposed by newcleo for its planned French MOX fuel facility, concluding that the provisions adopted by the Company for its safety approach are satisfactory at this stage.

In December 2024, newcleo submitted a safety approach dossier to the French nuclear safety authority for its planned MOX fuel fabrication facility in France.

Following its review, the ASNR has concluded that the provisions proposed by newcleo for the facility’s safety demonstrations which are envisioned are satisfactory and, overall, are capable of meeting the objectives established under the applicable French nuclear safety framework.

The ASNR’s opinion also identifies areas to be developed further as the project advances. newcleo intends to incorporate the ASNR’s recommendations into the facility design in support of a future construction license application.